Article
The association of dimethylarginine dimethylaminohydrolase 1 gene polymorphism with type 2 diabetes: a cohort study.
Cardiovascular diabetology - 9 Feb 2011
Lu Tse-Min, Lin Shing-Jong, Lin Ming-Wei, Hsu Chiao-Po, Chung Ming-Yi
Abstract excerpt
BACKGROUND: Elevated plasma levels of asymmetric dimethylarginine (ADMA) has been reported to be associated with insulin resistance and micro/macrovascular diabetic complications, and may predict cardiovascular events in type 2 diabetic patients. Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is the major enzyme eliminating ADMA in humans, but the effect of genetic variations in DDAH1 on type 2 diabetes and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
